INLIF Limited (INLF)
| Market Cap | 44.11M |
| Revenue (ttm) | 18.41M |
| Net Income (ttm) | -5.45M |
| Shares Out | 13.81M |
| EPS (ttm) | -5.26 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,866 |
| Open | 3.220 |
| Previous Close | 3.230 |
| Day's Range | 3.190 - 3.220 |
| 52-Week Range | 3.140 - 28.000 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 6, 2026 |
About INLF
INLIF Limited, through its subsidiaries, engages in the research, development, manufacture, and sale of injection molding machine-dedicated manipulator arms under the iNLIF brand in the People’s Republic of China. The company offers transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms, as well as manipulator arms accessories, including conveyor belt clamps, welded bases, and reducer mounting plates. It also provides installation and warranty s... [Read more]
Financial Performance
Financial StatementsNews
INLIF LIMITED Announces 1-for-16 Share Combination as Part of Strategic Nasdaq Compliance Initiative
QUANZHOU, China, March 31, 2026 (GLOBE NEWSWIRE) -- INLIF LIMITED (NASDAQ: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the rese...
INLIF LIMITED Reports Fiscal Year 2025 Financial Results
QUANZHOU, China, March 6, 2026 /PRNewswire/ -- INLIF LIMITED (Nasdaq: INLF) (the "Company" or "INLIF"), a company engaged in the research, development, manufacturing, and sales of injection molding ma...
INLIF LIMITED Commences Phase II Construction of Its Robotics Digital Intelligent Manufacturing Base, Expanding Capacity and Output
Quanzhou, China, Nov. 05, 2025 (GLOBE NEWSWIRE) -- INLIF LIMITED (Nasdaq: INLF) (the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection moldin...
INLIF LIMITED Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Quanzhou, China, Oct. 30, 2025 (GLOBE NEWSWIRE) -- INLIF LIMITED (Nasdaq: INLF) (the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection moldin...
INLIF LIMITED Accelerates Expansion into New Energy Sector to Drive Long-term Strategic Transformation
Quanzhou, China, Oct. 23, 2025 (GLOBE NEWSWIRE) -- INLIF LIMITED (Nasdaq: INLF) (the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection moldin...
INLIF LIMITED Reports First Half of Fiscal Year 2025 Financial Results
QUANZHOU, China , Sept. 29, 2025 /PRNewswire/ -- INLIF LIMITED (Nasdaq: INLF) (the "Company" or "INLIF"), a company engaged in the research, development, manufacturing, and sales of injection molding ...
INLIF LIMITED Reports Fiscal Year 2024 Financial Results
QUANZHOU, China , April 29, 2025 /PRNewswire/ -- INLIF LIMITED (Nasdaq: INLF) (the "Company" or "INLIF"), a company engaged in the research, development, manufacturing, and sales of injection molding ...
INLIF LIMITED Announces Closing of US$8 Million Initial Public Offering
Quanzhou, China, Jan. 03, 2025 (GLOBE NEWSWIRE) -- INLIF LIMITED (Nasdaq: INLF) (the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection moldin...